Clinical trial
A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome
NCT00362752 · Unity Health Toronto, Other · Completed
Key facts
| NCT number | NCT00362752 |
|---|---|
| Title | A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome |
| Official title | A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome |
| Lead sponsor | Unity Health Toronto, Other |
| Collaborators | University of Toronto |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatopulmonary Syndrome |
| Intervention type | Drug |
| Interventions | Norfloxacin, Placebo |
| Enrollment | 9 |
| Start date | Oct 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Aug 10, 2006 |
| Last update posted | Dec 7, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: